View : 537 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author황승균-
dc.date.accessioned2018-05-18T08:15:15Z-
dc.date.available2018-05-18T08:15:15Z-
dc.date.issued2005-
dc.identifier.issn1042-3680-
dc.identifier.otherOAK-2602-
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/243197-
dc.description.abstractUntreated cerebral AVMs carry a significant risk of long-term morbidity and mortality. Endovascular embolization has evolved into an important treatment option for most AVMs, whether it is used as an adjunct or as the primary therapy. Although sometimes a challenge to use, liquid cyanoacrylate derivatives have become the material of choice for most practitioners performing endovascular AVM embolization. In addition, advances in flow-guided microcatheter technology have enabled safer access to ever more hard-to-reach areas of the cerebral vasculature. In the current era, the treatment of cerebral AVMs seems to be best approached from a multidisciplinary standpoint at facilities where the major treatment modalities of microsurgery, stereotactic radiosurgery, and endovascular embolization are all available.-
dc.languageEnglish-
dc.titleEndovascular treatment of cerebral arteriovenous malformations: Indications, techniques, outcome, and complications-
dc.typeReview-
dc.relation.issue2 SPEC. ISS.-
dc.relation.volume16-
dc.relation.indexSCIE-
dc.relation.indexSCOPUS-
dc.relation.startpage367-
dc.relation.lastpage380-
dc.relation.journaltitleNeurosurgery Clinics of North America-
dc.identifier.doi10.1016/j.nec.2004.08.001-
dc.identifier.wosidWOS:000227342700016-
dc.identifier.scopusid2-s2.0-13244255466-
dc.author.googleCockroft K.M.-
dc.author.googleHwang S.-K.-
dc.author.googleRosenwasser R.H.-
dc.contributor.scopusid황승균(35187436400)-
dc.date.modifydate20180517114100-
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE